Physician profile
John Lanzone
NPI 1407851082
$3,369.25
in general payments reported to CMS, 2019-2025
16 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $442 · 2021: $518 · 2022: $499 · 2023: $639 · 2024: $471 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,362.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,083.18 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $559.68 | 2020-2025 | |
| Pfizer INC. | $435.69 | 2019-2025 | |
| Esperion Therapeutics, INC. | $269.18 | 2022-2025 | Nexletol |
| Amgen INC. | $263.99 | 2019-2024 | Repatha |
| Sanofi-Aventis U.S. LLC | $130.52 | 2019-2023 | |
| Astrazeneca Pharmaceuticals Lp | $121.23 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $108.00 | 2022-2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $100.29 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.44 | 2019-2020 | |
| Abbott Laboratories | $50.71 | 2021-2024 | Mitraclip |
| Inspire Medical Systems, INC. | $49.11 | 2024 | Inspire |
| Kowa Pharmaceuticals America, INC. | $38.93 | 2019-2022 | |
| Medicomp INC | $32.92 | 2023 | Telepatch Cardiac Monitor |
| Preventice Services, LLC | $21.94 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $21.44 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lanzone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.